false 0001494891 0001494891 2024-05-31 2024-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 31, 2024

 

SENSUS HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37714   27-1647271
(State of Incorporation)   (Commission File Number)   (IRS Employer
Identification No.)

 

851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida   33487
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 922-5808

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   SRTS   Nasdaq Stock Market, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

SENSUS HEALTHCARE, INC.

 

FORM 8-K

CURRENT REPORT

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

The Annual Meeting of Stockholders (the “Annual Meeting”) of Sensus Healthcare, Inc, (the “Company”) was held on May 31, 2024. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act of 1934, and there was no solicitation in opposition to the Company’s solicitation. The following summarizes all matters voted on at the Annual Meeting.

 

1. Election of Directors. Megan Cornish and Joseph Sardano were elected as Class III directors for a three-year term to expire in 2027 or until their respective successors are elected and qualified. Each nominee was an incumbent director, and no other person was nominated. The tabulation of votes cast was as follows:

 

   For   Against   Abstention   Broker Non-Votes 
Megan Cornish   8,588,606    666,421    127,971    4,108,050 
Joseph Sardano   8,789,668    563,106    30,224    4,108,050 

 

2. Amendment of the Company’s Amended and Restated Certificate of Incorporation. Stockholders approved an amendment of the Company’s Amended and Restated Certificate of Incorporation to permit the exculpation of officers in certain circumstances, as permitted by Delaware law. The tabulation of votes cast was as follows:

 

For   Against   Abstention   Broker Non-Votes
8,795,359   251,690   335,949   4,108,050

 

3. Advisory Vote on Executive Compensation. Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2023. The tabulation of votes cast was as follows:

 

For   Against   Abstention   Broker Non-Votes
8,552,812   416,554   413,632   4,108,050

 

4. Auditor Appointment Ratification. Stockholders ratified the appointment of Marcum LLP as the Company’s independent registered public accountant for the fiscal year ended December 31, 2024. The tabulation of votes cast was as follows:

 

For   Against   Abstention
13,111,490   52,543   327,015

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SENSUS HEALTHCARE, INC.
   
Date: June 5, 2024 By: /s/ Javier Rampolla
    Javier Rampolla
    Chief Financial Officer

 

 

2

 

v3.24.1.1.u2
Cover
May 31, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 31, 2024
Entity File Number 001-37714
Entity Registrant Name SENSUS HEALTHCARE, INC.
Entity Central Index Key 0001494891
Entity Tax Identification Number 27-1647271
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 851 Broken Sound Pkwy.
Entity Address, Address Line Two NW # 215
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33487
City Area Code 561
Local Phone Number 922-5808
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol SRTS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Sensus Healthcare (NASDAQ:SRTS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Sensus Healthcare.
Sensus Healthcare (NASDAQ:SRTS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Sensus Healthcare.